ISR - The Buzz Show: Isoray Inc. (NYSE: ISR) Surges Upon FDA Clearance of its Sirius® Positive-Signal

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ Isoray Inc. Surges Upon FDA Clearance of its Sirius® Positive-Signal ”

Isoray Inc. (NYSE: ISR) shot up over 227% in premarket trading after C4 Imaging announced its receipt of an FDA clearance.

C4 Imaging announced FDA clearance for the use of its Sirius® positive-signal MRI Markers with Isoray’s Cesium-131, brachytherapy seeds.

Isoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com .

For more information, please visit: Isoray Inc.

About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.

For further details see: